Seastar Medical Holding CORP S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
SeaStar Medical Holding Corporation has filed an S-1/A amendment to register up to 2,000,000 shares of common stock for resale by Lincoln Park Capital Fund, LLC.
NASDAQ
SeaStar Medical Holding Corporation is registering for resale up to 1,664,543 shares of its Common Stock by Lincoln Park Capital Fund, LLC, with potential proceeds up to $14.7 million.
NASDAQ
SeaStar Medical Holding Corporation is registering shares for resale by securityholders, while grappling with significant losses, Nasdaq compliance issues, and ongoing capital needs despite recent product commercialization.
NASDAQ
SeaStar Medical Holding Corporation is offering up to 5.15 million shares of common stock and accompanying warrants to raise approximately $4.3 million in net proceeds, as the company faces substantial doubt about its ability to continue as a going concern and a Nasdaq delisting threat.
NASDAQ
SeaStar Medical Holding Corporation has filed an S-1 registration statement to offer up to 4.2 million shares and accompanying warrants, seeking to raise capital for its medical device development and commercialization efforts while addressing ongoing Nasdaq listing compliance issues and advancing its pivotal adult AKI clinical trial.
NASDAQ
SeaStar Medical plans to raise up to $15 million by reselling common stock through Lincoln Park Capital Fund, aiming to bolster working capital and general corporate purposes.